Jun 2026 (Q2 FY26) — Aug 13, 2026
GDS Holdings Q2 FY26 — Record Bookings and Raised Sales Target
Read the full callGDS Holdings earnings: last reported Thu, 13 Aug 2026, for the quarter ended Jun 2026.
Price
1Y: $32.73 on 17 Oct 2025 → $22.47. High $47.52 (27 Jan 2026), low $22.47 (19 Oct 2026).
Overview
Call summaries
GDS Holdings Q2 FY26 — Record Bookings and Raised Sales Target
Read the full callGDS Holdings Q1 FY26 — Strong AI-Driven Bookings and Capacity Expansion
Read the full callGDS Holdings Limited Q4 FY25 — Strong Bookings and AI-Driven Demand
Read the full callEvery analysed call
Financials
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -235 | -296 | -417 | -616 | -751 | -1,333 | -828 | -728 |
| Total liabilities | 2,234 | 2,893 | 4,679 | 7,200 | 7,339 | 7,646 | 6,847 | 7,465 |
| Fixed assets | 2,035 | 2,756 | 4,527 | 6,395 | 6,801 | 5,644 | 5,508 | 5,436 |
| Total assets | 3,037 | 4,524 | 8,758 | 11,276 | 10,844 | 10,478 | 10,090 | 11,427 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2 | 42 | 49 | 189 | 407 | 291 | 266 | 481 |
| Cash from investing | -688 | -737 | -1,434 | -2,155 | -1,814 | -1,034 | -1,200 | -434 |
| Cash from financing | 709 | 1,201 | 3,081 | 1,278 | 891 | 585 | 2,337 | 872 |
| Net cash flow | 49 | 530 | 1,609 | -703 | -456 | -136 | 1,400 | 907 |
| Capital expenditure | -620 | -655 | -1,229 | -1,527 | -850 | -450 | -434 | -670 |
| Free cash flow | -621 | -613 | -1,180 | -1,338 | -443 | -159 | -169 | -189 |
| KPI | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Backlog | <600 MWOur backlog has increased to over 200,000 square meters or almost 600 megawatts most of which we will become billable within the next 6 to 8 quarters.Source: earnings call transcript | 757 MWBy the middle of the year, our backlog had increased substantially to 757 megawatts.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
46 filings between Apr 30, 2026 and Oct 15, 2026.
Purchases
None
No insider bought shares.
Sales
$1.71M
2 sales by 2 insiders
Also filed: 21 other filings.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Ye Judy Qing | — | $1.35M | Jun 2, 2026 |
| Qian Yixin | — | $352.5K | Jun 10, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Chen Kathy Hua Director | Award | 1,890 | $0 |
| Oct 15, 2026 | Ye Judy Qing Director | Award | 1,540 | $0 |
| Oct 15, 2026 | SIO TAT HIANG Director | Award | 2,500 | $0 |
| Oct 15, 2026 | YU BIN Director | Award | 1,610 | $0 |
| Oct 15, 2026 | KING JONATHAN ALLEN Insider | Award | 210 | $0 |
| Oct 15, 2026 | Sun Qiang Chang Director | Award | 1,330 | $0 |
| Oct 15, 2026 | LOPEZ BRUNO Director | Award | 1,750 | $0 |
| Oct 15, 2026 | Zhang David Director | Award | 1,330 | $0 |
| Oct 15, 2026 | Liu Chee Ming Director | Award | 1,330 | $0 |
| Oct 15, 2026 | Wojtaszek Gary J Director | Award | 1,330 | $0 |
| Oct 15, 2026 | BAHARUDIN ZULKIFLI BIN Director | Award | 2,030 | $0 |
| Aug 3, 2026 | Zhang Kejing EVP, sales and service | Other | 12,166 | $0 |
| Aug 3, 2026 | Newman Daniel Antony Chief financial officer | Other | 51,374 | $0 |
| Aug 3, 2026 | Liang Yan See Remarks | Other | 11,166 | $0 |
| Aug 3, 2026 | Qian Yixin Executive VP, operation | Other | 12,800 | $0 |
| Aug 3, 2026 | Huang William Wei Chairman and CEO | Other | 53,334 | $0 |
| Jul 15, 2026 | Liu Chee Ming Director | Award | 1,130 | $0 |
| Jul 15, 2026 | Chen Kathy Hua Director | Award | 740 | $0 |
| Jul 15, 2026 | YU BIN Director | Award | 1,370 | $0 |
| Jul 15, 2026 | LOPEZ BRUNO Director | Award | 1,500 | $0 |
| Jul 15, 2026 | Sun Qiang Chang Director | Award | 1,130 | $0 |
| Jul 15, 2026 | Wojtaszek Gary J Director | Award | 1,130 | $0 |
| Jul 15, 2026 | SIO TAT HIANG Director | Award | 2,130 | $0 |
| Jul 15, 2026 | Ye Judy Qing Director | Award | 1,320 | $0 |
| Jul 15, 2026 | BAHARUDIN ZULKIFLI BIN Director | Award | 1,740 | $0 |
| Jul 15, 2026 | Zhang David Director | Award | 75 | $0 |
| Jul 15, 2026 | KING JONATHAN ALLEN Insider | Award | 180 | $0 |
| Jun 10, 2026 | Qian Yixin Executive VP, operation | Sale | 10,000 | $352.5K |
| Jun 2, 2026 | Ye Judy Qing Director | Sale | 37,394 | $1.35M |
| May 22, 2026 | Zhang Kejing EVP, sales and service | Other | 17,313 | $0 |
| May 22, 2026 | Zhang Kejing EVP, sales and service | Tax withheld | 5,899 | $199.4K |
| May 15, 2026 | LIM AH DOO Director | Other | 1,390 | $0 |
| May 15, 2026 | YU BIN Director | Other | 1,190 | $0 |
| May 15, 2026 | SIO TAT HIANG Director | Other | 1,840 | $0 |
| May 15, 2026 | Liu Chee Ming Director | Other | 980 | $0 |
| May 15, 2026 | Ye Judy Qing Director | Other | 1,140 | $0 |
| May 15, 2026 | LOPEZ BRUNO Director | Other | 1,290 | $0 |
| May 15, 2026 | Sun Qiang Chang Director | Other | 980 | $0 |
| May 15, 2026 | BAHARUDIN ZULKIFLI BIN Director | Other | 1,500 | $0 |
| May 15, 2026 | Wojtaszek Gary J Director | Other | 980 | $0 |
| May 15, 2026 | KING JONATHAN ALLEN Insider | Other | 160 | $0 |
| May 15, 2026 | Okada Satoshi Director | Other | 980 | $0 |
| Apr 30, 2026 | Newman Daniel Antony Chief financial officer | Other | 161,492 | $0 |
| Apr 30, 2026 | Liang Yan See Remarks | Other | 20,775 | $0 |
| Apr 30, 2026 | Qian Yixin Executive VP, operation | Other | 52,660 | $0 |
| Apr 30, 2026 | Huang William Wei Chairman and CEO | Other | 200,888 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow GDS Holdings Ltd and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading